Grants per year
Personal profile
Research Interests
Undergraduate studies: University of Rochester, BS 1981 Postgraduate studies: SUNY StonyBrook School of Medicine, MD 1986 Internship and Residency, SUNY StonyBrook: Internal Medicine 1986-1989 Chief Resident, SUNY StonyBrook: 1989-1990 Fellowship, Pulmonary and Critical Care Medicine, SUNY StonyBrook: 1990-1993 Northwestern University Kellogg School of Business, MBA: 2006-2008 Board Certification: Internal Medicine, Pulmonary Medicine, Critical Care Medicine
My academic focus parallels my clinical focus. My clinically research has explored the risk of lung cancer in patients with scleroderma and the role of esophageal enlargement in progression of lung disease in Scleroderma. More recently, my research interests have expanded in working with our basic scientists to explore the pathobiology of inflammation, injury and fibrosis in the lungs of patients with ILD and pulmonary fibrosis.
My clinic area of interest and expertise is in the evaluation and management of interstitial lung disease with a particular focus on lung disease associated with connective tissue diseases such as scleroderma, myositis and other connective tissue diseases. I am the director of the Interstitial Lung Disease Program at Northwestern University and run our multidisciplinary ILD bimonthly conference.
Certifications and Licenses
Critical Care Medicine | |
Pulmonary Disease | |
Internal Medicine |
Training Experience
1990 | Residency, University Hospital - SUNY |
1993 | Fellowship, University Hospital - SUNY |
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Medicine, MD, SUNY Stony Brook
… → 1990
Research interests keywords
- Connective Tissue Associated Interstitial Lung Disease
- Idiopathic Interstitial Lung Disease
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Prot #RIN‐PF‐302: An Open‐label Extension Study of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis
Dematte D'Amico, J. E. (PD/PI)
United Therapeutics Corporation
8/18/23 → 8/18/26
Project: Research project
-
Prot #GB44496: A Two‐Cohort, Phase II, Multicenter, Randomized, Double‐Blind, Parallel‐Group, Placebo‐Controlled Study Evaluating the Efficacy and Safety of Vixarelimab Compared with Placebo in Patients with Idiopathic Pulmonary Fibrosis and in Patients
Dematte D'Amico, J. E. (PD/PI)
PPD Investigator Services, LLC, Genentech, Inc
6/26/23 → 8/10/27
Project: Research project
-
Prot #1366-0031: A Phase II, Randomised, Placebo-controlled, Double-blind, Parallel-group, Efficacy and Safety Study of at Least 48 Weeks of Oral BI 685509 Treatment in Adults with Early Progressive Diffuse Cutaneous Systemic Sclerosis
Dematte D'Amico, J. E. (PD/PI)
Boehringer Ingelheim Pharmaceuticals, Inc.
3/24/23 → 3/24/26
Project: Research project
-
Molecular Biomarkers To Guide Therapy In The Systemic Sclerosis-Associated Interstitial Lung Disease
Misharin, A. (PD/PI) & Dematte D'Amico, J. E. (Co-PD/PI)
10/19/22 → 10/18/25
Project: Research project
-
Three Distinct Transcriptional Profiles of Monocytes Associate with Disease Activity in Scleroderma Patients
Makinde, H. K. M., Dunn, J. L. M., Gadhvi, G., Carns, M., Aren, K., Chung, A. H., Muhammad, L. N., Song, J., Cuda, C. M., Dominguez, S., Pandolfino, J. E., Dematte D'Amico, J. E., Budinger, G. S., Assassi, S., Frech, T. M., Khanna, D., Shaeffer, A., Perlman, H., Hinchcliff, M. & Winter, D. R., Apr 2023, In: Arthritis and Rheumatology. 75, 4, p. 595-608 14 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Advances in the management of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis
Liu, G. Y., Budinger, G. R. S. & Dematte, J. E., 2022, (Accepted/In press) In: The BMJ. e066354.Research output: Contribution to journal › Review article › peer-review
Open Access32 Scopus citations -
Comparison of Forceps, Cryoprobe, and Thoracoscopic Lung Biopsy for the Diagnosis of Interstitial Lung Disease - The CHILL Study
Wahidi, M. M., Argento, A. C., Mahmood, K., Shofer, S. L., Giovacchini, C., Pulsipher, A., Hartwig, M., Tong, B., Carney, J. M., Colby, T., Neely, B., Wang, X., Dematte, J., Ninan, N., Danoff, S., Morrison, L. D. & Yarmus, L., Apr 1 2022, In: Respiration. 101, 4, p. 394-400 7 p.Research output: Contribution to journal › Article › peer-review
Open Access15 Scopus citations -
Local and systemic responses to SARS-CoV-2 infection in children and adults
NU SCRIPT Study Investigators, Feb 10 2022, In: Nature. 602, 7896, p. 321-327 7 p.Research output: Contribution to journal › Article › peer-review
Open Access168 Scopus citations -
Provider Perspectives on and Access to Palliative Care for Patients With Interstitial Lung Disease
Pulmonary Fibrosis Foundation, Aug 2022, In: CHEST. 162, 2, p. 375-384 10 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations